Covaxin Cleared For 6-12 Age Group
The Drugs Controller General of India (DCGI) today gave restricted use authorisation to Bharat Biotech's Covaxin for chi...
The Drugs Controller General of India (DCGI) today gave restricted use authorisation to Bharat Biotech's Covaxin for chi...
The Gavi vaccine alliance is in talks with Bharat Biotech over potential procurement of the company's Covaxin COVID-19 s...
Covaxin, one of the main vaccines used in India's coronavirus immunization drive, provides only 50% protection against s...
Two doses of Covaxin are 50 per cent effective against symptomatic disease, according to the first real-world assessment...
Covaxin, a vaccine developed by government's medical research agency and Bharat Biotech International Ltd., was found to...
The World Health Organization has granted Bharat Biotech's Covaxin an Emergency Use Listing, said sources on Wednesday e...
External Affairs Minister S Jaishankar on Wednesday said the WHO''s decision to grant emergency use approval to Bharat B...
COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable...
With a review process of Covaxin, the indigenous vaccine against COVID-19, commencing at the World Health Organisation,...
Controversy over a $324 million deal between Brazil and Bharat Biotech - for the import of 20 million Covaxin doses - co...